Product Availability Update

 

Further to DrugAlert Volume 142, HPS Pharmacies are pleased to advise that our careful management of stocks of DBL Morphine Sulfate Injection 5mg, 10mg, 15mg, 30mg should see our clients unaffected by the current supply problems experienced by Hospira.

Hospira has experienced a delivery hold up of DBL Morphine Sulfate Injection 10mg/mL that has also created a higher demand and short supply of DBL Morphine Sulfate Injection 5mg, 15mg, and 30mg. These shortages are expected to continue until mid 2013.

Hospira has obtained approval to distribute morphine 10mg/mL from Wockhardt UK Ltd under Section 19a of the Therapeutic Goods Act 1989 to commence from mid January 2013 until regular stocks return to normal.

This product contains a preservative and therefore cannot be used for epidural or intrathecal administration. The Wockhardt Morphine Sulphate 10mg/1mL Injection is approved for subcutaneous, intravenous or intramuscular routes as advised on the label which is coloured olive and blue.

Should the Wockhardt Morphine Sulphate 10mg/1mL Injection be introduced into your facility, posters in landscape and portrait orientation are available to educate and inform staff. Further information is available from the TGA website at http://www.tga.gov.au/hp/information-medicines-morphine-sulfate-products.htm.

Please retain this notice in a prominent position, including other related business units, until supplies return to normal. Should you require further information regarding this matter, please do not hesitate to contact your pharmacist at HPS Pharmacies or Customer Service at Hospira on 1300 046 774.

Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates